Stock 6955 SHANDONG BOAN BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shandong Boan Biotechnology Co., Ltd.

Equities

6955

CNE100005RV4

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:08 27/06/2024 BST 		5-day change 1st Jan Change
9.07 HKD -0.87% Intraday chart for Shandong Boan Biotechnology Co., Ltd. -0.87% -41.48%
05-28 China Accepts Boan Biotechnology's Biologics License Application for Type 2 Diabetes Drug MT
05-27 Shandong Boan Biotechnology Co., Ltd. Announces Acceptance of BLA in China for Dulaglutide Injection CI

Business Summary

Shandong Boan Biotechnology Co Ltd is a China-based company primarily engaged in biopharmaceuticals. The Company is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The Company has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The Company operates mainly in the domestic Chinese market and overseas markets.

Number of employees: 813

Sales per Business

HKD in Million2022Weight2023Weight Delta
High Quality Biologics
100.0 %
600 100.0 % 683 100.0 % +13.84%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
600 100.0 % 683 100.0 % +13.84%

Managers

Managers TitleAgeSince
Jiang Hua CEO
 Chief Executive Officer 46 21/06/20
Shenghan Wang DFI
 Director of Finance/CFO 44 31/08/20
Chang Lin Dou CTO
 Chief Tech/Sci/R&D Officer 61 13/12/17
Deyong Song PRN
 Corporate Officer/Principal 42 31/12/21
Jun Lu PRN
 Corporate Officer/Principal 58 08/03/15
Guangming Chi PRN
 Corporate Officer/Principal 59 24/03/22
Dou Changlin
61 -
Siu Kuen Lai SEC
 Corporate Secretary 48 09/03/22

Members of the board

Members of the board TitleAgeSince
Yuan Chong Liu BRD
 Director/Board Member 60 21/06/20
Lu Wen Shi BRD
 Director/Board Member 60 22/03/21
Ji Xiong Dai BRD
 Director/Board Member 65 22/03/21
Chang Lin Dou CTO
 Chief Tech/Sci/R&D Officer 61 13/12/17
Jiang Hua CEO
 Chief Executive Officer 46 21/06/20
Dou Changlin
61 -
Li Li BRD
 Director/Board Member 49 21/06/20
Xiaomei Zhang CHM
 Chairman 53 22/03/21
Xia Ning BRD
 Director/Board Member 35 22/03/21
Jia Lin Yu BRD
 Director/Board Member 47 01/12/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 509,278,094 101,042,970 ( 19.84 %) 0 19.84 %

Shareholders

NameEquities%Valuation
LUYE PHARMA GROUP LTD.
70.81 %
360,596,456 70.81 % 421 M $
Yantai Bolian Investment Center LP
4.205 %
21,415,548 4.205 % 25 M $
Yantai Bosheng Investment Center LP
2.936 %
14,954,632 2.936 % 17 M $
Yantai Bofa Investment Center LP
2.213 %
11,268,488 2.213 % 13 M $
Jiang Hua
1.767 %
9,000,000 1.767 % 11 M $
Suzhou Industrial Park Bioventure Investment Management Ltd.
1.697 %
8,642,788 1.697 % 10 M $
Dou Changlin
1.335 %
6,800,000 1.335 % 8 M $
Harvest Global Investments Ltd.
0.9917 %
5,050,400 0.9917 % 6 M $
Yuan Chong Liu
0.7854 %
4,000,000 0.7854 % 5 M $
Estate Of Li You Xin
0.2945 %
1,500,000 0.2945 % 2 M $

Company contact information

Shandong Boan Biotechnology Co., Ltd.

No. 39 Keji Avenue High-Tech Industrial

261312, Yantai

+86 53 5437 9111

http://www.boan-bio.com
address Shandong Boan Biotechnology Co., Ltd.(6955)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for Shandong Boan Biotechnology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8.514 CNY
Average target price
10.44 CNY
Spread / Average Target
+22.62%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
SHANDONG BOAN BIOTECHNOLOGY CO., LTD. Stock Shandong Boan Biotechnology Co., Ltd.
-41.48% 597M
CSL LIMITED Stock CSL Limited
+2.97% 94.74B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-4.08% 37.28B
BIOGEN INC. Stock Biogen Inc.
-13.26% 32.68B
UCB Stock UCB
+73.83% 27.72B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-11.58% 16.19B
INCYTE CORPORATION Stock Incyte Corporation
-1.66% 13.88B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.67% 11.58B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+190.36% 10.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-52.61% 9.54B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6955 Stock
  4. Company Shandong Boan Biotechnology Co., Ltd.